Publication
The Clinical Development of Percutaneous Heart Valve Technology: A Position Statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI)
Thomas A. Vassiliades, Jr, Peter C. Block, Lawrence H. Cohn, David H. Adams, Jeffrey S. Borer, Ted Feldman, David R. Holmes, Warren K. Laskey, Bruce W. Lytle, Michael J. Mack and David O. Williams
This joint position statement represents the combined efforts of four professional societies (Society of Thoracic Surgeons [STS], American Association for Thoracic Surgery [AATS], American College of Cardiology [ACC], and Society for Cardiovascular Angiography and Interventions [SCAI]), two government agencies (the U.S. Food and Drug Administration [FDA] and the Centers for Medicare and Medicaid Services [CMS]), and numerous industry representatives to assess the foreseeable directions of a class of emerging technologies being developed to enable the percutaneous treatment of cardiac valve dysfunction.
Page Created: January 04, 2018
Last Updated: January 04, 2018
Share
Publications
-
Aortic Arch Replacement: How I Teach It
Amine Mazine, Nitish K Dhingra, Michael W A Chu, Ismail El-Hamamsy, Mark D Peterson -
Mitral Annular Disjunction: A Contrary View
Dimosthenis Pandis, MD, MSc, Anelechi C. Anyanwu, MD, FRCS, David H. Adams, MD, FACC -
Direct access hybrid transatrial implantation of a Sapien 3 valve inside a bioprosthetic mitral valve with concomitant tricuspid valve replacement and cryoablation
Sophia L. Alexis, Gilbert H. L. Tang, Dimosthenis Pandis, David H. Adams, Ahmed El-Eshmawi -
The Ross procedure: total root technique
Elbert E Williams, Ismail El-Hamamsy